ID   AK1C4_HUMAN             Reviewed;         323 AA.
AC   P17516; Q5T6A3; Q8WW84; Q9NS54;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   15-MAR-2017, entry version 186.
DE   RecName: Full=Aldo-keto reductase family 1 member C4;
DE            EC=1.1.1.-;
DE   AltName: Full=3-alpha-HSD1;
DE   AltName: Full=3-alpha-hydroxysteroid dehydrogenase type I;
DE            EC=1.1.1.357;
DE   AltName: Full=Chlordecone reductase;
DE            Short=CDR;
DE            EC=1.1.1.225;
DE   AltName: Full=Dihydrodiol dehydrogenase 4;
DE            Short=DD-4;
DE            Short=DD4;
DE   AltName: Full=HAKRA;
GN   Name=AKR1C4; Synonyms=CHDR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ARG-250.
RC   TISSUE=Liver;
RX   PubMed=8274401; DOI=10.1016/0960-0760(93)90308-J;
RA   Qin K.-N., New M.I., Cheng K.-C.;
RT   "Molecular cloning of multiple cDNAs encoding human enzymes
RT   structurally related to 3 alpha-hydroxysteroid dehydrogenase.";
RL   J. Steroid Biochem. Mol. Biol. 46:673-679(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY, AND VARIANT
RP   ARG-250.
RX   PubMed=7650035; DOI=10.1074/jbc.270.34.20162;
RA   Khanna M., Qin K.-N., Wang R.W., Cheng K.-C.;
RT   "Substrate specificity, gene structure, and tissue-specific
RT   distribution of multiple human 3 alpha-hydroxysteroid
RT   dehydrogenases.";
RL   J. Biol. Chem. 270:20162-20168(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ARG-250.
RX   PubMed=7626489; DOI=10.1016/0960-0760(95)00019-V;
RA   Khanna M., Qin K.-N., Cheng K.-C.;
RT   "Distribution of 3 alpha-hydroxysteroid dehydrogenase in rat brain and
RT   molecular cloning of multiple cDNAs encoding structurally related
RT   proteins in humans.";
RL   J. Steroid Biochem. Mol. Biol. 53:41-46(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS CYS-145; ARG-250 AND VAL-311.
RC   TISSUE=Liver;
RX   PubMed=10634139;
RA   Kume T., Iwasa H., Shiraishi H., Yokoi T., Nagashima K., Otsuka M.,
RA   Terada T., Takagi T., Hara A., Kamataki T.;
RT   "Characterization of a novel variant (S145C/L311V) of 3alpha-
RT   hydroxysteroid/dihydrodiol dehydrogenase in human liver.";
RL   Pharmacogenetics 9:763-771(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANT ARG-250.
RC   TISSUE=Liver;
RX   PubMed=10672042; DOI=10.1046/j.1365-2443.2000.00310.x;
RA   Nishizawa M., Nakajima T., Yasuda K., Kanzaki H., Sasaguri Y.,
RA   Watanabe K., Ito S.;
RT   "Close kinship of human 20alpha-hydroxysteroid dehydrogenase gene with
RT   three aldo-keto reductase genes.";
RL   Genes Cells 5:111-125(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION OF 3-ALPHA-HSD ACTIVITY,
RP   TISSUE SPECIFICITY, AND VARIANT ARG-250.
RC   TISSUE=Liver;
RX   PubMed=11158055; DOI=10.1210/jcem.86.2.7216;
RA   Dufort I., Labrie F., Luu-The V.;
RT   "Human types 1 and 3 3 alpha-hydroxysteroid dehydrogenases:
RT   differential lability and tissue distribution.";
RL   J. Clin. Endocrinol. Metab. 86:841-846(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS TYR-170 AND
RP   ARG-250.
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-323, AND VARIANT ARG-250.
RC   TISSUE=Liver;
RX   PubMed=2187532; DOI=10.1021/bi00456a034;
RA   Winters C.J., Molowa D.T., Guzelian P.S.;
RT   "Isolation and characterization of cloned cDNAs encoding human liver
RT   chlordecone reductase.";
RL   Biochemistry 29:1080-1087(1990).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-323, PROTEIN SEQUENCE OF 5-29; 76-131;
RP   184-201 AND 271-294, AND VARIANT ARG-250.
RC   TISSUE=Liver;
RX   PubMed=8172617; DOI=10.1042/bj2990545;
RA   Deyashiki Y., Ogasawara A., Nakayama T., Nakanishi M., Miyabe Y.,
RA   Sato K., Hara A.;
RT   "Molecular cloning of two human liver 3 alpha-
RT   hydroxysteroid/dihydrodiol dehydrogenase isoenzymes that are identical
RT   with chlordecone reductase and bile-acid binder.";
RL   Biochem. J. 299:545-552(1994).
RN   [11]
RP   PROTEIN SEQUENCE OF 40-54; 105-121; 162-175; 184-196; 277-291 AND
RP   307-321, AND CHARACTERIZATION AS 3-ALPHA-HSD.
RX   PubMed=1530633; DOI=10.1016/0006-291X(92)91260-W;
RA   Binstock J.M., Iyer R.B., Hamby C.V., Fried V.A., Schwartz I.S.,
RA   Weinstein B.I., Southren A.L.;
RT   "Human hepatic 3 alpha-hydroxysteroid dehydrogenase: possible identity
RT   with human hepatic chlordecone reductase.";
RL   Biochem. Biophys. Res. Commun. 187:760-766(1992).
RN   [12]
RP   INVOLVEMENT IN SRXY8.
RX   PubMed=21802064; DOI=10.1016/j.ajhg.2011.06.009;
RA   Fluck C.E., Meyer-Boni M., Pandey A.V., Kempna P., Miller W.L.,
RA   Schoenle E.J., Biason-Lauber A.;
RT   "Why boys will be boys: two pathways of fetal testicular androgen
RT   biosynthesis are needed for male sexual differentiation.";
RL   Am. J. Hum. Genet. 89:201-218(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH NADP.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human 3-alpha hydroxysteroid/dihydrodiol
RT   dehydrogenase (AKR1C4) complexed with NADP+.";
RL   Submitted (FEB-2006) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the transformation of the potent androgen
CC       dihydrotestosterone (DHT) into the less active form, 5-alpha-
CC       androstan-3-alpha,17-beta-diol (3-alpha-diol). Also has some 20-
CC       alpha-hydroxysteroid dehydrogenase activity. The biotransformation
CC       of the pesticide chlordecone (kepone) to its corresponding alcohol
CC       leads to increased biliary excretion of the pesticide and
CC       concomitant reduction of its neurotoxicity since bile is the major
CC       excretory route.
CC   -!- CATALYTIC ACTIVITY: Chlordecone alcohol + NADP(+) = chlordecone +
CC       NADPH.
CC   -!- CATALYTIC ACTIVITY: A 3-alpha-hydroxysteroid + NAD(P)(+) = a 3-
CC       oxosteroid + NAD(P)H.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|Ref.14}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Liver specific. {ECO:0000269|PubMed:11158055,
CC       ECO:0000269|PubMed:7650035}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- POLYMORPHISM: The allele with Cys-145/Val-311 shows a three- to
CC       five-fold decrease in catalytic efficiency for xenobiotic and
CC       steroidal substrates compared to the Ser-145/Leu-311 allele.
CC   -!- DISEASE: 46,XY sex reversal 8 (SRXY8) [MIM:614279]: A disorder of
CC       sex development. Affected individuals have a 46,XY karyotype but
CC       present as phenotypically normal females.
CC       {ECO:0000269|PubMed:21802064}. Note=The gene represented in this
CC       entry may act as a disease modifier. A splicing mutation resulting
CC       in loss of AKR1C4 exon 2 has been found in affected individuals
CC       carrying a causative mutation in AKR1C2 (PubMed:21802064). These
CC       patients manifest a more severe disease phenotype than individuals
CC       only carrying mutations in AKR1C2. {ECO:0000269|PubMed:21802064}.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA35658.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S68287; AAD14010.1; -; mRNA.
DR   EMBL; AB045829; BAA99542.1; -; mRNA.
DR   EMBL; AB031085; BAA92885.1; -; mRNA.
DR   EMBL; AB032163; BAA92893.1; -; Genomic_DNA.
DR   EMBL; AL355303; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC020744; AAH20744.1; -; mRNA.
DR   EMBL; M33375; AAA35658.1; ALT_INIT; mRNA.
DR   EMBL; D26125; BAA05122.1; -; mRNA.
DR   CCDS; CCDS7064.1; -.
DR   PIR; A57407; A57407.
DR   PIR; S59620; S59620.
DR   RefSeq; NP_001809.3; NM_001818.3.
DR   UniGene; Hs.567245; -.
DR   PDB; 2FVL; X-ray; 2.40 A; A/B/C=1-323.
DR   PDBsum; 2FVL; -.
DR   ProteinModelPortal; P17516; -.
DR   SMR; P17516; -.
DR   BioGrid; 107534; 4.
DR   STRING; 9606.ENSP00000263126; -.
DR   BindingDB; P17516; -.
DR   ChEMBL; CHEMBL4999; -.
DR   DrugBank; DB00157; NADH.
DR   SwissLipids; SLP:000000805; -.
DR   iPTMnet; P17516; -.
DR   PhosphoSitePlus; P17516; -.
DR   BioMuta; AKR1C4; -.
DR   DMDM; 308153631; -.
DR   EPD; P17516; -.
DR   MaxQB; P17516; -.
DR   PaxDb; P17516; -.
DR   PeptideAtlas; P17516; -.
DR   PRIDE; P17516; -.
DR   DNASU; 1109; -.
DR   Ensembl; ENST00000263126; ENSP00000263126; ENSG00000198610.
DR   Ensembl; ENST00000380448; ENSP00000369814; ENSG00000198610.
DR   GeneID; 1109; -.
DR   KEGG; hsa:1109; -.
DR   UCSC; uc001ihw.2; human.
DR   CTD; 1109; -.
DR   DisGeNET; 1109; -.
DR   GeneCards; AKR1C4; -.
DR   HGNC; HGNC:387; AKR1C4.
DR   HPA; HPA044720; -.
DR   HPA; HPA068265; -.
DR   MalaCards; AKR1C4; -.
DR   MIM; 600451; gene.
DR   MIM; 614279; phenotype.
DR   neXtProt; NX_P17516; -.
DR   OpenTargets; ENSG00000198610; -.
DR   Orphanet; 90796; 46,XY disorder of sex development due to isolated 17,20 lyase deficiency.
DR   PharmGKB; PA24680; -.
DR   eggNOG; KOG1577; Eukaryota.
DR   eggNOG; COG0656; LUCA.
DR   GeneTree; ENSGT00760000119041; -.
DR   HOGENOM; HOG000250272; -.
DR   HOVERGEN; HBG000020; -.
DR   InParanoid; P17516; -.
DR   KO; K00037; -.
DR   OMA; LLHFPMA; -.
DR   OrthoDB; EOG091G0D69; -.
DR   PhylomeDB; P17516; -.
DR   TreeFam; TF106492; -.
DR   BioCyc; MetaCyc:HS10739-MONOMER; -.
DR   BRENDA; 1.1.1.357; 2681.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-HSA-193775; Synthesis of bile acids and bile salts via 24-hydroxycholesterol.
DR   Reactome; R-HSA-193807; Synthesis of bile acids and bile salts via 27-hydroxycholesterol.
DR   Reactome; R-HSA-975634; Retinoid metabolism and transport.
DR   SABIO-RK; P17516; -.
DR   SIGNOR; P17516; -.
DR   EvolutionaryTrace; P17516; -.
DR   GeneWiki; 3-alpha-HSD; -.
DR   GenomeRNAi; 1109; -.
DR   PRO; PR:P17516; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000198610; -.
DR   CleanEx; HS_AKR1C4; -.
DR   Genevisible; P17516; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:Reactome.
DR   GO; GO:0047023; F:androsterone dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0015125; F:bile acid transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0047743; F:chlordecone reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:UniProtKB.
DR   GO; GO:0001758; F:retinal dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0008209; P:androgen metabolic process; TAS:ProtInc.
DR   GO; GO:0015721; P:bile acid and bile salt transport; TAS:ProtInc.
DR   GO; GO:0006699; P:bile acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0071395; P:cellular response to jasmonic acid stimulus; IDA:UniProtKB.
DR   GO; GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB.
DR   GO; GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   GO; GO:0008202; P:steroid metabolic process; TAS:ProtInc.
DR   CDD; cd06660; Aldo_ket_red; 1.
DR   Gene3D; 3.20.20.100; -; 1.
DR   InterPro; IPR018170; Aldo/ket_reductase_CS.
DR   InterPro; IPR020471; Aldo/keto_reductase.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   PANTHER; PTHR11732; PTHR11732; 1.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   PIRSF; PIRSF000097; AKR; 1.
DR   PRINTS; PR00069; ALDKETRDTASE.
DR   SUPFAM; SSF51430; SSF51430; 1.
DR   PROSITE; PS00798; ALDOKETO_REDUCTASE_1; 1.
DR   PROSITE; PS00062; ALDOKETO_REDUCTASE_2; 1.
DR   PROSITE; PS00063; ALDOKETO_REDUCTASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   NADP; Oxidoreductase; Polymorphism; Reference proteome.
FT   CHAIN         1    323       Aldo-keto reductase family 1 member C4.
FT                                /FTId=PRO_0000124640.
FT   NP_BIND      20     24       NADP. {ECO:0000269|Ref.14}.
FT   NP_BIND     166    167       NADP. {ECO:0000269|Ref.14}.
FT   NP_BIND     216    221       NADP. {ECO:0000269|Ref.14}.
FT   NP_BIND     270    280       NADP. {ECO:0000269|Ref.14}.
FT   ACT_SITE     55     55       Proton donor. {ECO:0000250}.
FT   BINDING      50     50       NADP. {ECO:0000269|Ref.14}.
FT   BINDING     117    117       Substrate. {ECO:0000250}.
FT   BINDING     190    190       NADP. {ECO:0000269|Ref.14}.
FT   SITE         54     54       Important for substrate specificity.
FT                                {ECO:0000250}.
FT   SITE         84     84       Lowers pKa of active site Tyr.
FT                                {ECO:0000250}.
FT   VARIANT     135    135       G -> E (in dbSNP:rs11253043).
FT                                /FTId=VAR_028240.
FT   VARIANT     145    145       S -> C (in dbSNP:rs3829125).
FT                                {ECO:0000269|PubMed:10634139}.
FT                                /FTId=VAR_013290.
FT   VARIANT     170    170       C -> Y (in dbSNP:rs17851824).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_028241.
FT   VARIANT     250    250       Q -> R (in dbSNP:rs4880718).
FT                                {ECO:0000269|PubMed:10634139,
FT                                ECO:0000269|PubMed:10672042,
FT                                ECO:0000269|PubMed:11158055,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2187532,
FT                                ECO:0000269|PubMed:7626489,
FT                                ECO:0000269|PubMed:7650035,
FT                                ECO:0000269|PubMed:8172617,
FT                                ECO:0000269|PubMed:8274401}.
FT                                /FTId=VAR_028242.
FT   VARIANT     311    311       L -> V (in dbSNP:rs17134592).
FT                                {ECO:0000269|PubMed:10634139}.
FT                                /FTId=VAR_013291.
FT   HELIX         3      5       {ECO:0000244|PDB:2FVL}.
FT   STRAND        7      9       {ECO:0000244|PDB:2FVL}.
FT   STRAND       15     22       {ECO:0000244|PDB:2FVL}.
FT   HELIX        33     44       {ECO:0000244|PDB:2FVL}.
FT   STRAND       48     50       {ECO:0000244|PDB:2FVL}.
FT   HELIX        53     55       {ECO:0000244|PDB:2FVL}.
FT   HELIX        58     71       {ECO:0000244|PDB:2FVL}.
FT   HELIX        76     78       {ECO:0000244|PDB:2FVL}.
FT   STRAND       80     85       {ECO:0000244|PDB:2FVL}.
FT   HELIX        87     89       {ECO:0000244|PDB:2FVL}.
FT   HELIX        92    106       {ECO:0000244|PDB:2FVL}.
FT   STRAND      111    117       {ECO:0000244|PDB:2FVL}.
FT   STRAND      124    126       {ECO:0000244|PDB:2FVL}.
FT   HELIX       144    156       {ECO:0000244|PDB:2FVL}.
FT   STRAND      159    167       {ECO:0000244|PDB:2FVL}.
FT   HELIX       170    177       {ECO:0000244|PDB:2FVL}.
FT   STRAND      187    192       {ECO:0000244|PDB:2FVL}.
FT   HELIX       200    208       {ECO:0000244|PDB:2FVL}.
FT   STRAND      212    217       {ECO:0000244|PDB:2FVL}.
FT   TURN        225    227       {ECO:0000244|PDB:2FVL}.
FT   HELIX       235    237       {ECO:0000244|PDB:2FVL}.
FT   HELIX       239    247       {ECO:0000244|PDB:2FVL}.
FT   HELIX       252    262       {ECO:0000244|PDB:2FVL}.
FT   STRAND      266    270       {ECO:0000244|PDB:2FVL}.
FT   HELIX       274    280       {ECO:0000244|PDB:2FVL}.
FT   HELIX       281    285       {ECO:0000244|PDB:2FVL}.
FT   HELIX       290    297       {ECO:0000244|PDB:2FVL}.
FT   HELIX       309    311       {ECO:0000244|PDB:2FVL}.
FT   STRAND      318    321       {ECO:0000244|PDB:2FVL}.
SQ   SEQUENCE   323 AA;  37067 MW;  E728CE4B420E8C58 CRC64;
     MDPKYQRVEL NDGHFMPVLG FGTYAPPEVP RNRAVEVTKL AIEAGFRHID SAYLYNNEEQ
     VGLAIRSKIA DGSVKREDIF YTSKLWCTFF QPQMVQPALE SSLKKLQLDY VDLYLLHFPM
     ALKPGETPLP KDENGKVIFD TVDLSATWEV MEKCKDAGLA KSIGVSNFNC RQLEMILNKP
     GLKYKPVCNQ VECHPYLNQS KLLDFCKSKD IVLVAHSALG TQRHKLWVDP NSPVLLEDPV
     LCALAKKHKQ TPALIALRYQ LQRGVVVLAK SYNEQRIREN IQVFEFQLTS EDMKVLDGLN
     RNYRYVVMDF LMDHPDYPFS DEY
//
